NexTec and Sage X3 Support TissueTech's Ongoing Innovation
TissueTech chose NexTec to upgrade its Sage X3 solution, which it originally implemented in 2014. With NexTec's help, TissueTech has extended the capabilities of its system and optimized its operations.
TissueTech, Inc. is a leader in innovative technologies. The company relies on a proprietary cryopreservation technology called CryoTek® to preserve the natural properties of umbilical cord and amniotic membrane human birth tissue products. Following the introduction of this proprietary cryopreserved amniotic membrane to the ophthalmic industry in 1997, TissueTech has pioneered the clinical application of human birth tissue-based products.
Here’s how NexTec Group and Sage X3 helped solve TissueTech’s challenges.
Sage X3 is speeding and streamlining TissueTech’s digital evolution. The software is designed as a multi-entity solution, capable of handling TissueTech’s complex structure. “We have two lines of business, and Sage X3 makes it very easy to manage those companies in a single pane of glass,” says Carlos Jofre Jr., Executive Director of IT at TissueTech.